 Double-blind study botulinum toxin adductor spasmodic dysphonia treatment adductor spasmodic dysphonia botulinum toxin patients double-blind placebo-controlled study Patients interdisciplinary team consisting speech pathologists otolaryngologist neurologist toxin saline thyroarytenoid muscle electromyographic laryngoscopic guidance Botulinum perturbation fundamental frequency range spectrographic characteristics voice Fundamental frequency phonation time unchanged Patients botulinum toxin noticed significant improvement voices comparison placebo-treated group Excessive breathiness voice patients mild bleeding patient botulinum toxin A-treated group Injection saline edema vocal cord patient Botulinum effective safe treatment adductor spasmodic dysphonia